Zhejiang Huahai Pharmaceutical co Ltd. Provided earnings guidance for the nine months of 2015. The company predicts an increase of 50% to 70% in its net profit belonging to shareholders of the listed company in the first three quarters of 2015 compared with the same period of the year before.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.53 CNY | -0.40% | +1.10% | +19.50% |
May. 13 | Huahai Pharmaceutical's Unit Gets Nod to Register Atomoxetine Hydrochloride Oral Solution | MT |
May. 02 | Huahai Pharmaceutical's Q1 Profit Jumps 57%, Income Up 21% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.50% | 3.56B | |
+37.86% | 705B | |
+32.82% | 583B | |
-3.71% | 364B | |
+19.79% | 332B | |
+5.01% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.87% | 169B |
- Stock Market
- Equities
- 600521 Stock
- News Zhejiang Huahai Pharmaceutical Co., Ltd.
- Zhejiang Huahai Pharmaceutical co Ltd Provides Earnings Guidance for the Nine Months of 2015